A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
Recs
marsuculix
(< 20)
Submitted: 23/05/2013 07:19:49 :
Start Price:
$79.86
PCYC.US Score:
+4.97
ASCO 2013 provides upside potential !
Recs
50daymovingshort
(39.36)
Submitted: 10/04/2013 05:11:33 :
Start Price:
$75.45
PCYC.US Score:
-6.74
This pick was made because its below the 50day moving average as of April 10th.
The whole list I perused through below 50dmva for 4/10/13 were;
AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CTXS
These tickers were picked from my tracking universe of the following tickers:
CCI,AMZN,SIRI,LMT,PNRA,SBAC,RPRX,PRAN,MDVN,VZ,ALXN,PCYC,CNQR,INFI,VRTX,PCLN,CRM,LULU,CVLT,NFLX,OPEN,GMCR,N,CAR,REGN,T,SBUX,MO,ULTI,MAR,EQIX,CTXS,CLH,BLL
This was supposed to be a simple tracking blog post rather than a pitch but as a new player, it takes a couple of days to be approved for blog posting...oh well. Hopefully I remember to look back at these pitches.
Recs
mchedester
(48.68)
Submitted: 22/03/2013 16:47:10 :
Start Price:
$80.64
PCYC.US Score:
-1.22
Great company with lots of cash that has been shooting up for a long time. I bought on the dip today and I'm buying in my motley fool caps as well.
Recs
buckeyefanboy
(93.81)
Submitted: 11/02/2013 12:52:10 :
Start Price:
$70.19
PCYC.US Score:
+11.26
They're finally profitable and they got profitable in a big way.
Recs
PrototypeZ
(< 20)
Submitted: 04/02/2013 17:27:10 :
Start Price:
$70.30
PCYC.US Score:
-10.15
Price levels are out of whack with fundamentals
Recs
tiredofit
(< 20)
Submitted: 30/01/2013 18:36:23 :
Start Price:
$68.01
PCYC.US Score:
+13.86
outperform
Recs
lewrose
(69.40)
Submitted: 23/12/2012 13:37:57 :
Start Price:
$60.25
PCYC.US Score:
+24.09
Game changing medication for several forms of leukemia, including CLL, about to be approved by FDA.
Recs
portefeuille
(99.75)
Submitted: 18/12/2012 22:53:43 :
Start Price:
$67.72
PCYC.US Score:
+8.09
http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.
Recs
SkepBioInvestor
(73.47)
Submitted: 09/10/2012 16:15:21 :
Start Price:
$65.33
PCYC.US Score:
+14.58
1 star caps rating? another reason why we should not rely on the so called TMF pros. Good lesson of humility for some of them.
Immunokinases are a hot target these days, as hot as the multibillion market opportunity of hematological cancers. Of course, any safety/efficacy issues and the stock will tank hard
Recs
Imhilion
(66.47)
Submitted: 18/09/2012 00:24:21 :
Start Price:
$63.14
PCYC.US Score:
-20.86
Parabolic technicals, stupidly overvalued fundamentals
Recs
BuffettJunior1
(97.63)
Submitted: 15/09/2012 19:35:39 :
Start Price:
$62.41
PCYC.US Score:
-22.76
Why is this stock valued as if all of the company's drugs have been approved? Ridiculous valuation for an early stage biotech!
Recs
BigFatBEAR
(30.14)
Submitted: 21/08/2012 01:56:17 :
Start Price:
$61.18
PCYC.US Score:
-22.01
Eegads... don't think I've ever seen so many highly-ranked fools with -1000+ points associated as with this stock. Maybe shipping or solar, back in the day. Anyway, underperform...
Recs
jwray01
(99.65)
Submitted: 18/07/2012 06:38:18 :
Start Price:
$53.04
PCYC.US Score:
-37.61
one anomolous quarter is pumping up their earnings and stock price. None of their drugs have even started stage 3 trials yet. Stock spammers love them.
Recs
TMFBiologyFool
(99.15)
Submitted: 02/07/2012 13:38:57 :
Start Price:
$57.52
PCYC.US Score:
-25.23
Ibrutinib has potential, but risk reward is too unfavorable after the run up.
Recs
phatchips767
(< 20)
Submitted: 27/06/2012 20:06:59 :
Start Price:
$53.90
PCYC.US Score:
+31.64
went to 300% increase for potofeille.
Recs
GoodTrader1
(< 20)
Submitted: 06/06/2012 16:38:42 :
Start Price:
$35.79
PCYC.US Score:
+111.79
high relative strenght
Recs
wabiri
(< 20)
Submitted: 13/02/2012 16:16:29 :
Start Price:
$25.07
PCYC.US Score:
+213.79
I think pcyc will hit $50.00 in 5years.
Recs
justaboutperfect
(22.38)
Submitted: 13/02/2012 08:59:12 :
Start Price:
$25.10
PCYC.US Score:
-213.42
What happens to a shooting star when it has no FDA approvals on products. It will need more cash to burn...
Recs
ExtremesTracker
(84.66)
Submitted: 09/02/2012 22:44:36 :
Start Price:
$19.60
PCYC.US Score:
-306.75
Skyrocketed based on expectations; no tangible results & more lofty expectations based on today's valuation compared to most other biotechs
Recs
NuclearSteve
(54.88)
Submitted: 25/01/2012 12:42:43 :
Start Price:
$18.36
PCYC.US Score:
+333.28
Strictly going off the genius Baker Brothers buying the stock. The fundamentals of this company look like any other infant-stage biotech... awful.
For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.
This page brought to you by USEQ\WEB21.
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 37 : 1 2 Next »